Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Knowledge Outputs

Featured publications

Publication records can include DOI links, downloads, authors, abstracts and indexing data.

Reset
5,279 results found Records are sourced from the KIU Publications module.
2025 School of Pharmacy

The Role of Brown and Beige Adipose Tissue Activation in Diabetes Prevention

Serunjogi Ruth

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 82-88

Brown and beige adipose tissues (BAT and BeAT) are thermogenic fat depots that dissipate energy as heat via uncoupling protein-1 (UCP1) and complementary UCP1-independent mechanisms. Their activation increases whole-body substrate oxidation, improves insulin...

2025 School of Pharmacy

The Role of Anemia in Maternal Mortality in African Countries: A Comparative Review

Ssenkayi Julius

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 76-81

Anemia in pregnancy is one of the most prevalent, multifactorial, and preventable contributors to maternal mortality in Africa. This comparative review synthesizes epidemiologic evidence, biological mechanisms, health-system determinants, and intervention str...

2025 School of Pharmacy

The Interplay between Microbiome and Circadian Rhythms

Ssenkayi Julius

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 68-75

The relationship between the microbiome and circadian rhythms has emerged as a critical area of biomedical research, highlighting the bidirectional communication between host biological clocks and microbial communities. Circadian rhythms regulate host metabol...

2025 School of Pharmacy

Telemedicine-Based Interventions for Gestational Diabetes Care: Efficacy, Accessibility, and Maternal-Fetal Outcomes

Ahereza Prissy

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 63-67

Gestational diabetes mellitus (GDM) affects 5–20% of pregnancies globally, depending on diagnostic criteria, and is associated with heightened risks of preeclampsia, macrosomia, neonatal hypoglycemia, and progression to type 2 diabetes mellitus in mothers. Tr...

2025 School of Pharmacy

Targeting Cancer Stem Cells Using Nanotechnology: Challenges and Opportunities

Ahereza Prissy

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 54-62

Cancer stem cells (CSCs) represent a subpopulation of tumor cells with self-renewal and tumor-initiating properties, playing a central role in tumor recurrence, metastasis, and resistance to conventional therapies. Despite advances in cancer treatment, target...

2025 School of Pharmacy

Smart Nanocarriers for Targeted Delivery of Antidiabetic Agents in Obesity-Linked Diabetes

Ahereza Prissy

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 43-53

Obesity-linked diabetes, driven by chronic inflammation, ectopic lipid deposition, and multi-organ insulin resistance, remains difficult to treat with conventional pharmacotherapy due to poor drug solubility, rapid degradation, off-target effects, and subopti...

2025 School of Pharmacy

Smart Nanocarriers and Stimuli-Responsive Systems in Obesity Management

Niwarinda Arnold

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 37-42

Obesity is a complex, multifactorial disease driven by genetic, metabolic, and behavioral factors. Conventional treatments, including pharmacotherapy and surgery, have limited long-term efficacy and often pose risks. Nanotechnology offers novel strategies for...

2025 School of Pharmacy

SGLT2 Inhibitors in Type 2 Diabetes Management: Renal Protection and Cardiovascular Outcomes

Niwarinda Arnold

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 33-36

Type 2 diabetes mellitus (T2DM) is a major driver of cardiovascular and renal morbidity worldwide. Despite advances in glucose-lowering therapies, patients remained at elevated risk for chronic kidney disease (CKD) and cardiovascular events, underscoring the...

2025 School of Pharmacy

Role of the Gut Microbiome in Type 1 and Type 2 Diabetes Pathogenesis

Ahereza Prissy

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 26-32

Diabetes mellitus, encompassing type 1 (T1D) and type 2 (T2D), has traditionally been viewed through lenses of genetics, autoimmunity, insulin resistance, and environmental risk factors such as diet and obesity. Recent advances in microbiome research have ide...

2025 School of Pharmacy

Precision Public Health Approaches

Ahereza Prissy

2025 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 19-25

Precision public health (PPH) represents an emerging paradigm that integrates data science, epidemiology, genomics, and social determinants of health to deliver more targeted, equitable, and effective population-level interventions. Unlike traditional public...